Nabil Daoud

Skip to main content

Meet the new Lilly EU
About Us
- About Lilly EU
- European Footprint
- About Lilly
Policy Positions
- View All
Resources
- European Citizen’s Perception Survey
- #WeWontRest
Responsibility
- Social Impact
- Transparency Registry
- Transparent Payments to Healthcare Providers
- Support to European Patient Organisations

Menu closed

Stories:
Featured
Policy
- View All
- Patient Access
- IP & Innovation
Health
- View All
- Alzheimer’s Disease
- COVID-19
- Diabetes
- Immunology
- Migraine
- Oncology
Lilly in Europe
- View All
- Country Profiles
- R&D and Manufacturing
- Life at Lilly

Meet the new Lilly EU
About Us
- About Lilly EU
- European Footprint
- About Lilly
Policy Positions
- View All
Resources
- European Citizen’s Perception Survey
- #WeWontRest
Responsibility
- Social Impact
- Transparency Registry
- Transparent Payments to Healthcare Providers
- Support to European Patient Organisations

A034981

Author:

Nabil Daoud

President of Lilly Spain, Portugal and Greece

Filter articles by

Toggle view

Loading...

Privacy Statement

Accessibility Statement

Social Media Guidelines

Cookie Settings

Copyright © 2020 Eli Lilly and Company. All rights reserved. For more information about Lilly's EU Government and Corporate Affairs activities, please email EuCorporateAffairs@lilly.com.

Terms of Use Privacy Statement Accessibility Statement Social Media Guidelines Sitemap Cookie Settings